Quick Answer
BioRestorative Therapies, Inc. reported Common Stock Shares Outstanding of 8.88 million shares for the year ending 2025.
- BioRestorative Therapies, Inc. showed an increase of +28.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from BioRestorative Therapies, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), BioRestorative Therapies, Inc.'s Common Stock Shares Outstanding has declined by 98.0%.
- Historical annual values: Fiscal year 2025: 8.88 million shares | Fiscal year 2024: 6.92 million shares | Fiscal year 2023: 4.71 million shares | Fiscal year 2022: 3.68 million shares | Fiscal year 2021: 3.52 million shares | Fiscal year 2020: 715,544 shares | Fiscal year 2019: 77.85 million shares | Fiscal year 2018: 11.73 million shares | Fiscal year 2017: 6.11 million shares | Fiscal year 2016: 4.70 million shares | Fiscal year 2015: 3.31 million shares | Fiscal year 2014: 1.70 million shares | Fiscal year 2013: 19.07 million shares | Fiscal year 2012: 14.88 million shares | Fiscal year 2011: 607.68 million shares | Fiscal year 2010: 433.22 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: